SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-128898
Filing Date
2020-11-24
Accepted
2020-11-24 13:45:48
Documents
12
Period of Report
2020-11-24
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2037046d1_8k.htm   iXBRL 8-K 37912
  Complete submission text file 0001104659-20-128898.txt   216461

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ntrp-20201124.xsd EX-101.SCH 3222
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ntrp-20201124_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ntrp-20201124_pre.xml EX-101.PRE 22734
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2037046d1_8k_htm.xml XML 3631
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 (973) 242-0005
Neurotrope, Inc. (Filer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38045 | Film No.: 201342295
SIC: 2834 Pharmaceutical Preparations